NexImmune Inc (NEXI)
0.3235
+0.10
(+46.31%)
USD |
OTCM |
Nov 14, 15:14
NexImmune Total Assets (Quarterly): 5.861M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.861M |
| March 31, 2024 | 8.991M |
| December 31, 2023 | 8.594M |
| September 30, 2023 | 14.56M |
| June 30, 2023 | 23.47M |
| March 31, 2023 | 30.66M |
| December 31, 2022 | 43.06M |
| September 30, 2022 | 57.67M |
| June 30, 2022 | 65.67M |
| Date | Value |
|---|---|
| March 31, 2022 | 78.31M |
| December 31, 2021 | 91.03M |
| September 30, 2021 | 104.54M |
| June 30, 2021 | 115.39M |
| March 31, 2021 | 126.57M |
| December 31, 2020 | 11.30M |
| September 30, 2020 | 6.694M |
| December 31, 2019 | 13.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.861M
Minimum
Jun 2024
126.57M
Maximum
Mar 2021
47.42M
Average
30.66M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.941M |
| Shareholders Equity (Quarterly) | 0.9205M |